Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram
Abstract Background The thrombin generation (TG) assay is a feasible but labor‐intensive method for detecting global coagulation. It enables comprehensive assessment of anticoagulation, while drug‐specific assays assess only exposure. Traditionally, the Calibrated Automated Thrombogram (CAT) has bee...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12497 |
id |
doaj-ef75b56cf1274601a77cff309d1e0a53 |
---|---|
record_format |
Article |
spelling |
doaj-ef75b56cf1274601a77cff309d1e0a532021-04-10T11:22:15ZengWileyResearch and Practice in Thrombosis and Haemostasis2475-03792021-03-015343944610.1002/rth2.12497Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated ThrombogramTuukka A. Helin0Marja Lemponen1Riitta Lassila2Lotta Joutsi‐Korhonen3Department of Clinical Chemistry HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital Helsinki FinlandDepartment of Clinical Chemistry HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital Helsinki FinlandCoagulation Disorders Unit Helsinki University HospitalResearch Program Unit in Systems OncologyUniversity of Helsinki Helsinki FinlandDepartment of Clinical Chemistry HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital Helsinki FinlandAbstract Background The thrombin generation (TG) assay is a feasible but labor‐intensive method for detecting global coagulation. It enables comprehensive assessment of anticoagulation, while drug‐specific assays assess only exposure. Traditionally, the Calibrated Automated Thrombogram (CAT) has been used, however the ST Genesia (Diagnostica Stago) allows automated evaluation. Objective We aimed to observe coagulation using the ST Genesia and compare the data with those of CAT in anticoagulated patients. Patients and methods In total, 43 frozen‐thawed samples were studied using DrugScreen to assess direct oral anticoagulants (DOACs), warfarin, and low‐molecular‐weight heparin. Twenty samples (nine rivaroxaban, five apixaban, three warfarin, and three heparin) were also compared using CAT (5 pM tissue factor). Results TG reduction in DrugScreen depended on the specific drug and modestly correlated with DOAC levels (lag time R2 = 0.36; peak R2 = 0.50). The best correlation was observed with peak thrombin and rivaroxaban‐specified anti–activated factor X (anti‐Xa) activity (R2 = 0.60). When comparing ST Genesia with CAT, only the results for apixaban concorded (R2 = 0.97). Unlike CAT, ST Genesia yielded a normal endogenous thrombin potential (ETP) in 77% (24/31) activated factor X inhibitor cases, and it failed to give readouts at international normalized ratio (INR) ≥4.5 and at anti‐Xa ≥1.0 IU/mL. Conclusion The ST Genesia data did not correlate with CAT, but it was independently associated with INR, anti‐Xa, and DOAC concentrations. The lag time and peak responses were similar; the major differences were that ST Genesia showed no ETP effect of DOACs and failed to give readout at high INR or anti‐Xa activity.https://doi.org/10.1002/rth2.12497anticoagulantscalibrationheparinthrombin/analysiswarfarin |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tuukka A. Helin Marja Lemponen Riitta Lassila Lotta Joutsi‐Korhonen |
spellingShingle |
Tuukka A. Helin Marja Lemponen Riitta Lassila Lotta Joutsi‐Korhonen Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram Research and Practice in Thrombosis and Haemostasis anticoagulants calibration heparin thrombin/analysis warfarin |
author_facet |
Tuukka A. Helin Marja Lemponen Riitta Lassila Lotta Joutsi‐Korhonen |
author_sort |
Tuukka A. Helin |
title |
Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram |
title_short |
Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram |
title_full |
Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram |
title_fullStr |
Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram |
title_full_unstemmed |
Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram |
title_sort |
anticoagulated patients exhibit intact endogenous thrombin potential using st genesia unlike the calibrated automated thrombogram |
publisher |
Wiley |
series |
Research and Practice in Thrombosis and Haemostasis |
issn |
2475-0379 |
publishDate |
2021-03-01 |
description |
Abstract Background The thrombin generation (TG) assay is a feasible but labor‐intensive method for detecting global coagulation. It enables comprehensive assessment of anticoagulation, while drug‐specific assays assess only exposure. Traditionally, the Calibrated Automated Thrombogram (CAT) has been used, however the ST Genesia (Diagnostica Stago) allows automated evaluation. Objective We aimed to observe coagulation using the ST Genesia and compare the data with those of CAT in anticoagulated patients. Patients and methods In total, 43 frozen‐thawed samples were studied using DrugScreen to assess direct oral anticoagulants (DOACs), warfarin, and low‐molecular‐weight heparin. Twenty samples (nine rivaroxaban, five apixaban, three warfarin, and three heparin) were also compared using CAT (5 pM tissue factor). Results TG reduction in DrugScreen depended on the specific drug and modestly correlated with DOAC levels (lag time R2 = 0.36; peak R2 = 0.50). The best correlation was observed with peak thrombin and rivaroxaban‐specified anti–activated factor X (anti‐Xa) activity (R2 = 0.60). When comparing ST Genesia with CAT, only the results for apixaban concorded (R2 = 0.97). Unlike CAT, ST Genesia yielded a normal endogenous thrombin potential (ETP) in 77% (24/31) activated factor X inhibitor cases, and it failed to give readouts at international normalized ratio (INR) ≥4.5 and at anti‐Xa ≥1.0 IU/mL. Conclusion The ST Genesia data did not correlate with CAT, but it was independently associated with INR, anti‐Xa, and DOAC concentrations. The lag time and peak responses were similar; the major differences were that ST Genesia showed no ETP effect of DOACs and failed to give readout at high INR or anti‐Xa activity. |
topic |
anticoagulants calibration heparin thrombin/analysis warfarin |
url |
https://doi.org/10.1002/rth2.12497 |
work_keys_str_mv |
AT tuukkaahelin anticoagulatedpatientsexhibitintactendogenousthrombinpotentialusingstgenesiaunlikethecalibratedautomatedthrombogram AT marjalemponen anticoagulatedpatientsexhibitintactendogenousthrombinpotentialusingstgenesiaunlikethecalibratedautomatedthrombogram AT riittalassila anticoagulatedpatientsexhibitintactendogenousthrombinpotentialusingstgenesiaunlikethecalibratedautomatedthrombogram AT lottajoutsikorhonen anticoagulatedpatientsexhibitintactendogenousthrombinpotentialusingstgenesiaunlikethecalibratedautomatedthrombogram |
_version_ |
1721531886721826816 |